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G protein-coupled receptors (GPCRs) are targets for a quarter of prescription drugs. Despite recent prog-
ress in structural biology of GPCRs, only few key conformational states in the signal transduction process
have been elucidated. Agonist ligands frequently display functional selectivity where activated receptors are
biased to either G protein- or arrestin-mediated downstream signaling pathways. Selective manipulation of
individual steps in the GPCR activation scheme requires precise information about the kinetics of ligand
binding and the dynamics of downstream signaling. One approach is to obtain time-resolved information
using receptors tagged with fluorescent or structural probes. Recent advances allow for site-specific
introduction of genetically encoded unnatural amino acids into expressed GPCRs. We describe how
bioorthogonal functional groups on GPCRs enable the mapping of receptor-ligand interactions and
how bioorthogonal chemical reactions can be used to introduce fluorescent labels for single-molecule fluo-
rescence applications to study the kinetics and conformational dynamics of GPCR signaling complexes
(‘‘signalosomes’’).Seven-transmembrane helical G protein-coupled receptors
(GPCRs) are highly dynamic membrane proteins that transmit
extracellular signals across the membrane to activate and
mediate several signaling pathways (Huber et al., 2008; Menon
et al., 2001). GPCRs play fundamental roles in a wide spectrum
of physiological and pathophysiological processes. In the
classical paradigm of GPCR signaling, an extracellular ligand
triggers ligand-induced conformational changes (Ye et al.,
2009, 2010) in the receptor that leads to recruitment of cyto-
solic heterotrimeric G proteins, which in turn activate enzyme
effectors to amplify the signal by generating a large number
of cellular second messengers (Katritch and Abagyan, 2011;
Steyaert and Kobilka, 2011). Recent advances in crystallog-
raphy have provided high-resolution structures of a growing
number of GPCRs in multiple conformational states, including
a G protein-bound complex (Hollenstein et al., 2014; Kobilka
and Schertler, 2008; Rasmussen et al., 2011), but there is
now a pressing need for additional biophysical and biochemical
techniques to achieve a precise understanding of the chemical
basis and structural dynamics of receptor activation and allo-
steric mechanism.
One very active area of research involves the biology of GPCR
oligomerization in cell membranes. In cell-based systems, GPCR
oligomerization has been studied using resonance energy
transfer (RET) assays that measure the proximity of donor and
acceptor probes (fluorescent and/or bioluminescent) attached
to target receptors (Ciruela et al., 2010). Although RET assays
have provided extensive data concerning GPCR oligomeriza-
tion (Pfleger and Eidne, 2005) and ligand-dependent receptor
coupling to cellular proteins, there are a number of inherent lim-
itations in these approaches (Bouvier et al., 2007; James et al.,
2006; Salahpour and Masri, 2007). Single-molecule detection
(SMD) fluorescence is another approach to visualize membrane1224 Chemistry & Biology 21, September 18, 2014 ª2014 Elsevier Ltprotein oligomers in membrane bilayers (Calebiro et al., 2013;
Hern et al., 2010; Kasai et al., 2011; Lin et al., 2014). In principle,
single molecule tracking can detect the movement of individual
oligomers and monitor association and dissociation events in
real time. The recent applications of single-molecule tracking
to study GPCRs were transformative because they provided ev-
idence for the existence of oligomers in living cells at essentially
physiological expression levels (Calebiro et al., 2013; Hern et al.,
2010; Prummer et al., 2006; Snaar-Jagalska et al., 2013; Suzuki
et al., 2005). However, the precise functional role of oligomeri-
zation, the structural basis for receptor association, and the
contributions of membrane lipids to the process remain ill
defined in part because of a lack of flexible and robust methods
to tag receptors in biological membranes.
Fluorescence techniques are indispensable for monitoring the
conformational states of purified receptors (Bockenhauer et al.,
2011; Dunham and Farrens, 1999; Gether et al., 1997; Peleg
et al., 2001) and receptors in live cells (Calebiro et al., 2013;
Hern et al., 2010; Kasai et al., 2011; Kusumi et al., 2010; Lohse
et al., 2012; Maurel et al., 2008; Vilardaga et al., 2009). In studies
of enzyme catalysis, multicolor SMD fluorescence techniques
allow the correlation of conformational dynamics of doubly
labeled enzymes to the binding of their labeled substrates
(Tinnefeld and Sauer, 2005). SMD approaches can in principle
detect both the function and stoichiometry of discrete bimolec-
ular complexes (Ha, 2013).
Transmembrane signaling is an allosteric process because
the conformational change induced in the receptor upon ligand
binding must be transmitted to the binding site of a cellular
transducer protein, such as a G protein or b arrestin, on the
opposite side of the membrane (Christopoulos and Kenakin,
2002). Different agonist ligands for the same receptor might
be biased for a particular signaling pathway, leading to thed All rights reserved
Figure 1. uaa Mutagenesis of GPCRs in Mammalian Cells
Amber stop codon (UAG) suppression technology is based on the presence of
an orthogonal suppressor amino acyl-tRNA. The suppressor tRNA is charged
with the uaa in a reaction catalyzed by an engineered orthogonal aminoacyl-
tRNA synthetase. Heterologous expression of GPCRs in mammalian cells
provides the most reliable approach to guarantee nativelike posttranslational
modifications and function (Sarramegna et al., 2003). HEK293T or HEK293F
cells are cotransfected with three different plasmids encoding the evolved
synthetase gene, the suppressor tRNA gene, and the gene encoding the
GPCR with an in-frame TAG mutation at a desired position. The orthogonal
tRNA/synthetase pair from bacteria does not cross-react with endogenous
mammalian tRNAs and synthetases, but the ribosome is able to utilize the
charged tRNA. Culturing the transfected cells in the presence of the uaa results
in protein translation, with suppression of the amber stop codon and site-
specific incorporation of the uaa at a desired position to give a full-length
protein (adapted from Daggett and Sakmar, 2011).
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and Christopoulos, 2013). A number of models have been pro-
posed to account for ligand bias and functional selectivity. One
hypothesis is that biased signaling can be described by multiple
signaling-competent receptor conformations that engage in
alternative ternary complexes (Rajagopal et al., 2010). An alter-
native hypothesis is that agonist bias may be predicted by dif-
ferential conformational changes in the ligand-receptor complex
alone (Horst et al., 2013; Liu et al., 2012), but it is generally
accepted that the fully active conformation is normally not
reached without a G protein- or b arrestin-binding partner
(Nygaard et al., 2013). Elucidating the molecular mechanism
of receptor allosterism and signaling bias requires quantification
of the strength of allosteric coupling. This strength is accessible
due to the reciprocity principle (Fenton, 2008); i.e., the changes
of agonist affinity due to binding of a transducer are equal in
magnitude to the changes of the transducer affinity shift due
to binding of the agonist. For example, the G protein-dependent
shift in agonist affinity correlates with intrinsic agonist activity
(Kent et al., 1980), and a similar correlation is found for b ar-
restin-dependent agonist affinity shifts (Gurevich et al., 1997).
Some allosteric interactions exhibit neutral cooperativity (i.e.,
no observable shift in affinities), but they still show pronounced
changes in ligand binding and dissociation kinetics (Christopou-
los and Kenakin, 2002). Therefore, it has been argued that ex-
periments to measure ligand dissociation kinetics are superior
to study allosteric effects (Avlani et al., 2004; Kostenis and
Mohr, 1996; Lazareno and Birdsall, 1995). We suggest that
single-molecule fluorescence techniques facilitated by site-Chemistry & Biology 2directed fluorescence labeling of GPCRs will be extremely use-
ful to monitor the effects of G protein and b arrestin on ligand
binding and dissociation kinetics.
In this review, we describe a transdisciplinary technology
platform that addresses the challenges inherent in single-mole-
cule studies of GPCRs. Our focus is on the chemical biology
approaches that should enable future quantitative studies of
GPCRs in biological membranes.
Amber Codon Suppression in Expressed GPCRs
Fluorescent reporters suitable for SMD fluorescence studies
include fluorescent proteins (GFP/RFP), semiconductor na-
nocrystals (quantum dots), and small organic fluorophores
(rhodamine or indocyanine dyes). Site-specific maleimide and
methanethiosulfonate Cys chemistries have been used to attach
conformation-sensitive probes, like spin labels in case of
rhodopsin (Altenbach et al., 2008; Hubbell et al., 2003; Huber
and Sakmar, 2008), or fluorescence labels for the b2-adrenergic
receptor (Ghanouni et al., 2001). However, to achieve single-
site labeling, this strategy ideally requires the introduction of a
Cys residue by site-directed mutagenesis into a highly engi-
neered ‘‘Cys-free’’ receptor. Since GPCRs contain multiple reac-
tive Cys residues, to engineer a satisfactory receptor substrate is
not trivial, especially since it is difficult to know a priori which Cys
residues are important for function and how mutagenesis might
alter receptor properties (Cordomı´ et al., 2013; Gether et al.,
1997; Karnik et al., 1988). Even in cases where ‘‘Cys-free’’ recep-
tors can be prepared and isolated, sulfhydryl chemistry is not bio-
orthogonal, and labeling receptors in a cellular context or in crude
extracts is not feasible. Therefore, purification of a target receptor
is required before thiol derivatization can be attempted.
To avoid targeting Cys residues, one strategy is to use unnat-
ural amino acid (uaa) mutagenesis for site-specific introduction
of unique functional groups that are not found in native proteins
(Figure 1). Bioorthogonal chemical reactions can then be used
to further derivatize the protein with fluorophores and other bio-
physical probes.
Twenty-five years ago, amber codon suppression (Goodman
et al., 1968; Laski et al., 1982) was combined with chemical mis-
acylation of tRNA (Hecht et al., 1978; Heckler et al., 1984) and
in vitro protein translation as a new technology for site-specific
incorporation of uaas with functional groups different from the
20 ‘‘proteinogenic’’ amino acids (Noren et al., 1989).
Stop codons (UAG, amber; UGA, opal; UAA, ochre) can be
used to expand the genetic code since they are uniquely identi-
fied by the eukaryotic release factor 1 (eRF1) (Frolova et al.,
1994; Song et al., 2000), whereas other codons typically are
recognized each by multiple tRNA genes (Geslain and Pan,
2010; Lander et al., 2001; Lavner and Kotlar, 2005; Novoa
et al., 2012). The overall efficiency of stop codon suppressor
tRNAs is determined by competition with eRF1/eRF3. Amber
stop codons are the least affected by eRF1/eRF3 competition
(Gubbens et al., 2010), which makes the amber stop codon
attractive for genetic encoding of uaas. Moreover, the frequency
of the amber stop codon in the complete protein coding genes
(CDSs) in Homo sapiens is only 23.5%, whereas ochre and
opal are used at 29.4% and 47.1%, respectively (see http://
www.kazusa.or.jp/codon) (Nakamura et al., 2000). Interestingly,
some eukaryotic organisms do not use all three stop codons, but1, September 18, 2014 ª2014 Elsevier Ltd All rights reserved 1225
Figure 2. Engineering of Amino Acyl-tRNA Synthetases to Recognize uaa
(A) Crystal structure of T. thermophilus Tyr-tRNA synthetase (Tyr-RS) (Yaremchuk et al., 2002) shows class II mode of tRNA recognition in a class I synthetase
(Ibba and Soll, 2000).
(B) Crystal structure of E. coli Tyr-RS dimer (Kobayashi et al., 2005) with closeup view of Tyr binding site residues engineered to recognize para-substituted Phe
analogs while rejecting Tyr (Chin et al., 2003).
(C–E) Efficiency and specificity of mutant E. coli Tyr-RS variants recognizing p-azido-Phe (azF). Amber suppression efficiency in the human HEK293T cell line was
evaluated using a luciferase reporter assay, which demonstrated efficient and specific incorporation of azF (Ye et al., 2008, 2009). Error bars represent the
standard error of the mean of three replicate experiments.
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Others use UAA/UAG as stop codons and UGA for Cys (Conard
et al., 2012). The unusual amino acid pyrrolysine (Pyl/O) is incor-
porated in response to the UAG amber codon in certain metha-
nogen archaebacteria (Srinivasan et al., 2002). Downregulation
of eRF1 has been used to increase the efficiency of uaam
(Carnes et al., 2003; Ilegems et al., 2004). The efficiency of trans-
lation termination is cell-type dependent; for example, HEK293
cells exhibit about 2% natural amber suppression, which is 10-
fold less than Chinese hamster ovary cells (Ilegems et al.,
2004). The natural amber suppression in mammalian cells is
codon context sensitive (Cassan and Rousset, 2001), which
theoretically should affect the efficiency of incorporation of
uaas using the amber codon-suppression strategy. Several
cytoplasmic tRNAs have been implicated in natural amber sup-
pression inmammalian cells, and it is likely that Gln (and possibly
Leu) residues will be incorporated as a result (Atkins and Geste-
land, 2002; Beier and Grimm, 2001). Moreover, aminoglycoside
antibiotics lead to substantial (up to 10%) read-through/sup-
pression of amber stop codons in mammalian cells (Burke and
Mogg, 1985; Floquet et al., 2012; Malik et al., 2010; Martin
et al., 1989; Phillips-Jones et al., 1995).
A method utilizing an engineered archaebacterial tyrosyl-
tRNA/synthetase pair in E. coli was reported where the archaeal
pair was orthogonal to eubacterial tRNAs and synthetases, but
the acylated tRNA is efficiently utilized by the E. coli ribosome.
The CUA anticodon was introduced in the tRNA to act as an1226 Chemistry & Biology 21, September 18, 2014 ª2014 Elsevier Ltamber suppressor tRNA. The mutation of the synthetase
was guided by crystallographic data (Figure 2) so that the
successfully engineered synthetase would recognize the tyro-
sine analog O-methyl-Tyr and reject Tyr as substrate (Wang
et al., 2001).
A similar strategy was used to introduce 3-iodo-Tyr by amber
codon suppression in mammalian cells. The orthogonal pair
tRNA/synthetase pair was a combination of E. coli Tyr-RS and
B. stearothermophilus suppressor tRNATyr (Sakamoto et al.,
2002). Later, the method was expanded to yeast (S. cerevisiae)
using the E. coli tyrosyl-tRNA/synthetase pair orthogonal to
the eukaryotic tRNAs and synthetases. The yeast system
enabled extensive genetic selection to specifically and efficiently
incorporate five different uaas (p-acetyl-, p-benzoyl-, p-azido-,
p-methoxy-, and p-iodo-Phe) (Chin et al., 2003).
We built on these findings and optimized the methodology
to improve dramatically the amber suppression efficiency by
generating a tRNA expression plasmid carrying a chimeric
gene of human and B. stearothermophilus suppressor tRNATyr
(Ye et al., 2008). Our chimeric tRNA gene expressed well, formed
an orthogonal pair with the E. coli Tyr-RS variants, and was effi-
ciently processed and acylated with Tyr and analogs in the hu-
man HEK293T cell line (Ye et al., 2008). The biosynthesis of
tRNA from our chimeric tRNA gene can be rationalized based
on detailed studies of the splicing and processing of the human
tRNATyr gene (MacPherson and Roy, 1986), which indicate that
spicing of the primary transcript precedes processing to trimd All rights reserved
Figure 3. Photocrosslinking and Bioorthogonal Labeling Reactions
(A) Photocrosslinking reaction with p-azido-Phe (azF).
(B) Photocrosslinking reaction with p-benzoyl-Phe (BzF).
(C) Oxime and hydrazone ligation reactions of p-acetyl-Phe (AcF).
(D) CuAAC of azF with a terminal alkyne reagent results in a 1,2,3-triazole
conjugate.
(E) Staudinger-Bertozzi ligation of azF with a phosphine reagent.
(F) SpAAC of azF with a DIBO reagent resulting in a 1,2,3-triazole conjugate.
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sequence on the 30 end (van Tol et al., 1987).
Besides bacteria (E. coli), yeast (S. cerevisiae), and mamma-
lian cells in culture (Chin, 2014; Liu and Schultz, 2010), uaamuta-
genesis methods have been developed for cultured insect cells
(Drosophila melanogaster Schneider 2 cells) (Mukai et al.,
2010), amphibian oocytes (Xenopus laevis) (Ye et al., 2013),
and two animals, the nematode Caenorhabditis elegans (Greiss
and Chin, 2011) and the arthropod Drosophila melanogaster
(Bianco et al., 2012).
Genetically Encoded uaas to Facilitate Biophysical and
Photochemical Crosslinking Studies of GPCRs
Using the strategy described above, we have been able
to incorporate uaas such as p-benzoyl-L-phenylalanine (BzF),
p-acetyl-L-phenylalanine (AcF), and p-azido-L-phenylalanine
(azF) into heterologously expressed GPCRs in mammalian cells
(Grunbeck et al., 2011, 2012; Huber et al., 2013; Naganathan
et al., 2013a, 2013b; Ray-Saha et al., 2014; Tian et al., 2013,
2014; Valentin-Hansen et al., 2014; Ye et al., 2008, 2009).
The photolabile uaas, BzF and azF, enabled the mapping
of ligand-binding sites on chemokine receptors (CXCR4 and
CCR5) (Grunbeck et al., 2011, 2012; Ray-Saha et al., 2014)
and on the substance P receptor NK1 (Valentin-Hansen et al.,
2014). Photochemical crosslinking experiments were carried
out in live cells prior to identification of crosslinked products.
When crosslinks occur, the site of the linkage on the receptor
is known since the photoreactive amino acid was genetically
encoded at a specific known site in the primary structure.
Crystal structure data or homology models were used to
interpret quantitative crosslinking data. Cell-based signaling
assays were carried out on engineered receptors in the
same cells and under the same conditions used for subse-
quent crosslinking reactions. The ‘‘targeted photocrosslinking’’
method was also used to map monoclonal antibody (mAb)
epitopes by crosslinking GPCR-mAb complexes (Ray-Saha
et al., 2014).
UV illumination of aromatic azides, such as azF, forms the
highly reactive nitrone that undergoes ring expansion and nucle-
ophile addition, resulting in chemical crosslinks (Bra¨se et al.,
2005) (Figure 3A). The long-wavelength UV light (365 nm) excites
the benzophenone group in BzF to a diradicaloid triplet state,
which either relaxes back to the benzophenone ground state
or reacts with surrounding molecular groups by H abstraction
and recombination to a photocrosslinked product (Dorma´n and
Prestwich, 1994) (Figure 3B). A chemical crosslinking method
was also reported using a p-fluoroacetyl-Phe (Ffact) residue in
the receptor that reacts with a nearby Cys residue introduced
in a peptide ligand (Coin et al., 2013).
To probe the biology of ion channels, electrophysiology exper-
iments with ionotropic glutamate receptors (iGluR) in Xenopus
oocytes (Zhu et al., 2014) and HEK293 cells (Klippenstein
et al., 2014) have demonstrated that the system for azF and
BzF incorporation (Ye et al., 2008, 2009) enables photocrosslink-
ing-based conformational switching of AMPA- and NMDA-type
iGluRs.
To study conformational dynamics of rhodopsin photoacti-
vation, the unique infrared vibrational spectrum of the azido
group was probed in a series of site-specific azF mutants.1, September 18, 2014 ª2014 Elsevier Ltd All rights reserved 1227
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measured to show that the electrostatic environments of some
residues change very early in the activation process (Ye et al.,
2009, 2010). These types of receptor dynamics experiments
can be correlated with high-resolution structures of receptor
activation intermediates to gain significant insights into the
biology of receptor signaling.
Bioorthogonal Labeling Strategies
Different bioorthogonal labeling strategies using AcF or azF have
been compared (Huber et al., 2013; Naganathan et al., 2013a,
2013b; Tian et al., 2013, 2014; Ye et al., 2008). Ketone groups
incorporated into a variety of proteins and other macromolecules
have facilitated novel ligation strategies such as hydrazone
and oxime ligation reactions that utilize aminooxy/hydroxylamine
(R = –O–R’) or hydrazide (R = –NH–CO–R’’) reagents (Figure 3C).
Under approximately physiological conditions, ketones and al-
dehydes react specifically with hydrazide (or aminooxy) reagents
through hydrazone (or oxime) ligation (Bayer et al., 1988; Wang
et al., 2003). The observation that aminooxy derivatives have
faster labeling kinetics at close to neutral pH as compared with
hydrazides is advantageous for protein labeling. These reactions
have been used to label proteins at genetically encoded
N-terminal aldehyde tags (Shi et al., 2012), enzymatically
coupled chemical handles (Chen et al., 2005), engineered cell
surface oligosaccharides (Hang and Bertozzi, 2001; Mahal
et al., 1997), and with more flexibility at site-specifically incorpo-
rated uaas (Cornish et al., 1996; de Graaf et al., 2009; Fleissner
et al., 2009; Wang and Schultz, 2004; Wang et al., 2003; Ye
et al., 2008; Zhang et al., 2003).
We observed substantial covalent modification of wild-type
rhodopsin and other control proteins that did not contain AcF
(Huber et al., 2013; Tian et al., 2014; Ye et al., 2008). This unde-
sired reactivity was caused by cellular oxidation processes
that convert some amino acid residues (Arg, Cys, His, Lys,
and Pro) to carbonyl derivatives that are reactive toward hy-
drazide and aminooxy reagents (Ahn et al., 1987; Stadtman
and Levine, 2003). This ‘‘protein carbonylation’’ phenomenon
severely limits the applicability of ketone-selective bio-
orthogonal labeling reactions (Grimsrud et al., 2008; Stadtman,
1993). The degree of target-specific background labeling due to
protein carbonylation will be roughly proportional to the pro-
tein’s molecular mass, with about one reactive carbonyl per
each thousand amino acid residues (Huber et al., 2013; Ye
et al., 2008).
Advantages of Bioorthogonal Azido Tags
The azido group has been reported to be a superior handle for
bioconjugation reactions (Bra¨se et al., 2005; Debets et al.,
2010b; Schilling et al., 2011; van Berkel et al., 2011). Azide pro-
vides an alternative bioorthogonal handle that can be incorpo-
rated in proteins by uaa mutagenesis. Azides react specifically
with phosphines through the Staudinger-Bertozzi ligation (see
below) (Kiick et al., 2002; Saxon and Bertozzi, 2000), with alkyne
reagents through Cu(I)-catalyzed [3+2] azide-alkyne cycload-
dition (CuAAC) (Meldal and Tornøe, 2008; Rostovtsev et al.,
2002; Tornøe et al., 2002), with oxanorbornadienes through
tandem [3+2] cycloaddition-retro-Diels-Alder (tandem crDA)
(van Berkel et al., 2007), or with cyclooctynes through strain-pro-1228 Chemistry & Biology 21, September 18, 2014 ª2014 Elsevier Ltmoted azide-alkyne cycloaddition (SpAAC) (Agard et al., 2004;
Debets et al., 2011; Link et al., 2006; Sletten and Bertozzi, 2011).
The discovery of a cell-compatible and selective ligation re-
action modeled after the classical Staudinger reaction between
an azide and a phosphine inspired the nascent field of bio-
orthogonal chemical reactions. This reaction, sometimes called
Staudinger-Bertozzi ligation, is a highly selective reaction
between modified triarylphosphines and azides to form an
aza-ylide intermediate that undergoes cyclization followed by
hydrolysis to form a stable amide-linked adduct (Ko¨hn and
Breinbauer, 2004; Saxon and Bertozzi, 2000; Saxon et al.,
2002; Tsao et al., 2005). It has been used to modify cell surface
glycans with haptenes, epitope tags, and fluorescent probes
(Chang et al., 2007; Cohen et al., 2010; Hangauer and Bertozzi,
2008; Kiick et al., 2002; Laughlin and Bertozzi, 2007; Lemieux
et al., 2003; Saxon and Bertozzi, 2000). It has also been used
to label azido amino acids in proteins in residue-specific (Kiick
et al., 2002) or site-specific (Mukai et al., 2010; Tsao et al.,
2005) manners. In another study, FLAG phosphine (FLAG is
a peptide epitope for a useful well-characterized mAb) was
used to label azido-bearing biotin. The FLAG biotin was then
used to tag an endogenous biotin acceptor protein (Slavoff
et al., 2008).
Despite the susceptibility of phosphines used for the Stau-
dinger ligation to air oxidation (Agard et al., 2004) and their sub-
stoichiometric modification of azF in recombinant proteins
(Huber et al., 2013; Yanagisawa et al., 2008) and azido sugars
(Agard et al., 2006), their compatibility to cell-based applica-
tions (Prescher et al., 2004) makes them attractive candidates
for further study.
In studies on GPCR labeling, we found that the reaction
yields essentially background-free product, consistent with
a truly bioorthogonal reaction (Huber et al., 2013). However,
despite reports of stoichiometric conjugation of azF in other
recombinant proteins with fluorescein-phosphine (Tsao et al.,
2005), we found that substoichiometric conjugation to azF
rhodopsin is not the result of its relatively slow reaction kinetics,
but possibly due to a classical Staudinger reaction instead
of the desired Staudinger-Bertozzi ligation. Consistent with
our findings, others have reported incomplete modification
of azF and a longer azido-containing pyrrolysine analog by
Staudinger ligation, which was attributed to the shorter linker
length between the backbone and the azide (Yanagisawa
et al., 2008).
In order to advance biological applications of novel labeling
methods, we developed a strategy to detect modified receptors
in live cells. We used the Staudinger ligation to modify azF res-
idues in the chemokine receptor CCR5 with a FLAG peptide-
epitope tag (Figure 4). One application of this technique is
a semihigh-throughput method to identify sites accessible
for site-specific labeling with other reagents like fluoro-
phores. Accessible sites are then used in a preparative method
to obtain purified receptors for SMD fluorescence work (Naga-
nathan et al., 2013b). In contrast to alternative methods
based on labeling Cys residues, such as the substituted Cys
accessibility method (Akabas et al., 1992; Zhu and Casey,
2007), the new method does not display cross-reactivity with
other Cys residues that are present in high abundance in the
cell.d All rights reserved
Figure 4. Staudinger-Bertozzi Ligation to Label azF Residues in CCR5
(A) Cell-based ELISA strategy to detect low abundance GPCRs labeled with FLAG-phosphine in a live cell context.
(B) Control experiments with wild-type CCR5, CCR5 with the keto amino acid AcF, and CCR5 with the azido amino acid azF demonstrate that specific labeling of
exposed resides is only achieved with azF-containing receptors. Error bars represent the standard error of the mean of three or more replicate experiments.
(C) Accessibility scan of azF residues incorporated in different position in CCR5 indicates that only a fraction of residues in a folded receptor is accessible to the
reactive label (Naganathan et al., 2013b).
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The catalytic action of Cu(I) in the Huisgen 1,3-dipolar azide-
alkyne cycloaddition (Huisgen et al., 1967) was reported by
two groups (Rostovtsev et al., 2002; Tornøe et al., 2002). The re-
action is now commonly called copper-catalyzed [3+2]
azide-alkyne cycloaddition (CuAAC) (Figure 3D). A significant
disadvantage for protein applications is that the reaction may
damage Cys, Met, and His residues in proteins and side reac-
tions can form reactive aldehydes that result in undesired pro-
tein adducts, crosslinks, and precipitation. Another problem is
that Cu(I) has extremely high affinity for Cys residues (Rubino
et al., 2011; Wu et al., 2010), and complete removal of the cata-
lyst is a challenge in protein conjugation reactions. Despite
these problems, the CuAAC reaction is very attractive since
the terminal alkyne and azide groups each are very small and
the resulting triazole linker is rather compact. The CuAAC reac-
tion has all the qualities of a ‘‘Click’’ reaction (Kolb et al., 2001); it
is orthogonal to other common reactions and functional groups
(Wong and Zimmerman, 2013), and it has made an enormous
impact in chemistry (Meldal and Tornøe, 2008), including drug
discovery (Devigny et al., 2011; Sakmar, 2011; Thirumurugan
et al., 2013).
In the search for alternatives to CuAAC, reactions of azides
with cyclooctyne, a ring-strained alkyne, were evaluated (Agard
et al., 2004). This reaction is also known as theWittig reaction, as
Wittig and Krebs identified the product, 1-phenyl-4.5-cyclooc-
teno-1.2.3-triazol (Wittig and Krebs, 1961), of an explosive reac-
tion between cyclooctyne and phenyl azide, described several
years earlier (Blomquist and Liu, 1953). The term strain-pro-
moted [3+2] azide-alkyne cycloaddition (SpAAC) was coined
for this new bioorthogonal bioconjugation reaction, which had
superior biocompatibility as compared with CuAAC and higherChemistry & Biology 2reaction efficiency as compared with the Staudinger-Bertozzi
reaction (Agard et al., 2006).
Dibenzocyclooctyne (DIBO) derivatives were developed for
SpAAC (Ning et al., 2008) based on a report of the spontaneous
reaction of phenyl azide with DIBO (Seitz et al., 1969), aza-biben-
zocyclooctynes were synthesized (DIBAC or DBCO) (Debets
et al., 2010a), biarylazacyclooctynones (BARACs) were intro-
duced (Jewett et al., 2010), and efficient syntheses of much
more hydrophilic bicyclononynes (BCNs) was demonstrated
(Dommerholt et al., 2010).
The Background Problem in SpAAC Reactions
Although SpAAC reactions involving cyclooctynes were
thought to be biocompatible (Prescher and Bertozzi, 2005)
and specific (Sletten and Bertozzi, 2011), the degradation of
one cyclooctyne (BARAC) in the presence of thiols (glutathione)
has been reported (Jewett et al., 2010), and background reac-
tions with Cys residues in proteins have been attributed to a
broad spectrum of cyclooctynes. Therefore, SpAAC is not
strictly bioorthogonal due to the reaction of cyclooctynes with
Cys residues in a thiol-yne addition reaction (van Geel et al.,
2012). However, we demonstrated the general utility of the
SpAAC reaction targeting azF residues with DIBO reagents in
GPCRs and concluded that it is a satisfactory choice for label-
ing expressed receptors with fluorophores and other probes
(Huber et al., 2013; Naganathan et al., 2013a; Tian et al.,
2013, 2014).
The kinetics of the SpAAC reaction of DIBO labeled probes
with azF residues in rhodopsin was up to 400-fold faster than
similar reactions of model compounds in organic solution
(Debets et al., 2011; Ning et al., 2008). This rate enhancement
was dependent on the labeling position. A similar effect was1, September 18, 2014 ª2014 Elsevier Ltd All rights reserved 1229
Figure 5. Regioisomeric and Stereoisomeric Forms of SpAAC
Conjugates
(A) The reaction of DBCO and azF results in anti- and syn-regioisomers.
(B) Bicyclo[6.1.0]nonyne (BCN) derivatives exist in two forms, endo and exo.
The reaction of endo-BCN with azF generates a new chiral center and two
diastereomeric reaction products.
(C) DIBO conjugated dyes are typically racemic mixtures, and the chiral ring
carbon of DIBO determines further enantiomeric forms of the triazole conju-
gate (S-anti, R-anti, S-syn, and R-syn).
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ally expressed GFP (Reddington et al., 2012). An increased local
concentration of the cyclooctyne group is likely due to the lipo-
philic nature of DIBO (Debets et al., 2011). In fact, our results indi-
cate efficient labeling of azF residues that are likely exposed to
the hydrophobic core of the detergent micelles stabilizing the
purified receptor preparations. Partitioning of the DIBO moiety
into the micelles would lead to increased local concentration
available for SpAAC (Tian et al., 2014).
Interestingly, the SpAAC reaction of Alexa488-DIBO with wild-
type rhodopsin results in approximately a 1% azF-independent
background labeling. This amount of background labeling is
substantially less than the amount (10%30%) observed for
AcF-independent background labeling of wild-type rhodopsin
with fluorescein-hydrazide (Huber et al., 2013; Tian et al., 2014;
Ye et al., 2008). Based on the amount of free Cys in rhodopsin
(Blaskovic et al., 2013; Karnik et al., 1988; Mielke et al., 2002;
Resek et al., 1993), we estimate that from two to eight Cys resi-
dues are potentially reactive toward DIBO. Consequently, a 1%
background labeling of wild-type rhodopsin would correspond
to a selectivity factor of DIBO for azF over Cys from 200:1 to
800:1, which is satisfactory bioorthogonality for a purified protein
system.
While a small degree of background labeling is inconsequen-
tial for SMD fluorescence experiments with purified receptors,
the abundance of Cys residues in cellular proteins severely limits
the applicability of SpAAC for experiments in cells. Cys-medi-
ated labeling of the proteome in the human HeLa cell line was
reported (van Geel et al., 2012). One estimate counted 214,000
Cys residues encoded in the mammalian genome (Jones,
2010). Amino acid analysis of mammalian cells shows aCys con-
tent of about 0.26% (Okayasu et al., 1997). The protein content of
a single HeLa cell can be estimated to be 247 pg (Bosmann et al.,
1968), which would correspond to 3 billion Cys residues per cell1230 Chemistry & Biology 21, September 18, 2014 ª2014 Elsevier Lt(in proteins). Considering our estimated selectivity factor of DIBO
for azide over Cys, even in the best case scenario, at least a few
million Cys residues per cell would be labeled as background.
Even the best expressing GPCR rarely yields more than about
6 million copies per cell (Sarramegna et al., 2003), which is on
the same order of magnitude as the expected Cys-based back-
ground labeling. The problem of Cys background is even more
aggravated for receptor densities typically desired for SMD fluo-
rescence tracking experiments (about 1 mm2) (Calebiro et al.,
2013; Hern et al., 2010). Considering the surface area of the
plasmamembrane (Sommerhage et al., 2008), this density corre-
sponds to only 2,500 receptors per cell. Clearly, additional
methods to enhance specificity will be necessary to enable
routine site-specific labeling and observation of low abundance
proteins directly in cells.
In the meantime, labeled receptors can be used to study the
pharmacology of ligand uptake and release reactions. For
example, the SpAAC reaction was used to label site specifically
and quantitatively azF-tagged rhodopsin with Alexa488-DIBO.
The kinetics of ligand uptake and release in labeled receptor
could be measured using fluorescence RET between the
Alexa488 and the covalently bound ligand, 11-cis-retinal, in a
membrane-mimetic bicelle system (Tian et al., 2014).
Progress toward Single-Molecule Studies of
Bioorthogonally Labeled GPCRs
Currently, there are several commercially available cyclooc-
tynes conjugated to fluorescence dyes suitable for SMD fluo-
rescence experiments. DBCO is also known as DIBAC or
ADIBO, depending on the substitution on the amide linker.
DIBO conjugates appear to form less unwanted reactions with
thiols as compared with BCN or DIBAC (van Geel et al.,
2012). On the other hand, BCN is much less hydrophobic than
DIBO or DIBAC (Debets et al., 2011), which are problematic in
combination with hydrophobic dyes such as Atto647N (Yao
et al., 2012). We anticipate that synthesis of fluorescent probes
based on these hydrophilic cyclooctynes, optimized linkers and
novel fluorophores with additional functionalities, such as triplet
state quenchers (Altman et al., 2012), will facilitate practical
application of SpAAC to label proteins for SMD fluorescence
experiments.
Preparation of Alexa647-DIBO site specifically conjugated
to azF-labeled rhodopsin was achieved by labeling of the
detergent-solubilized, purified receptor immobilized on an
immunoaffinity matrix (Tian et al., 2013). A model of the
Alexa647-DIBO-azF-rhodopsin conjugate illustrates the linker
length and the relative size of the fluorophore as compared
with the receptor (Figures 5 and 6). One can imagine that the
long and flexible linker generates uncertainty in the position of
the fluorophore, which might be problematic for distance mea-
surements using fluorescence RET. The RET efficiency depends
on the distance between the donor and acceptor fluorophores
and the orientational factor k2 that can assume values from
zero to four (Fo¨rster, 1948; Stryer and Haugland, 1967). Interest-
ingly, the intuitive solution to shorten the linker length to get a
better definition of the dye position may in fact be counterpro-
ductive and increase the uncertainty in calculations of the dis-
tance from the transfer efficiency due to nonrandom orientations
(k2s 2/3) (Sindbert et al., 2011). Computational methods, suchd All rights reserved
Figure 6. Three Color Single-Molecule Fluorescence Experiments with Alexa-DIBO Labeled azF-rhodopsin
(A) Alexa647 is a typical indocyanine-type fluorophore rendered hydrophilic by multiple sulfonate groups (White et al., 2006). The parent carboxylic acid form is
linked via an ethylenediamine linker to carboxymethylated DIBO, shown as the anti-triazolyl conjugate with azF.
(B) A 3D conformation of the Alexa647-DIBO-azF conjugate generated by semiempirical quantummechanics energy optimization. Note the relative orientation of
two benzo groups relative to the triazole on the cyclooctene. A representative Hu¨ckel molecular orbital is shown to illustrate the conjugation of the indocyanine
fluorophore.
(C) Alexa647-DIBO-azF manually modeled in position 144 of rhodopsin.
(D–H) Multicolor single-molecule detection total-internal reflection fluorescence imaging of amixture of azF-rhodopsin molecules labeled with the rhodamine dye
Alexa488-DIBO and the two cyanine dyes, Alexa555-DIBO and Alexa647-DIBO. (D) Raw image obtained with a QuadView image splitting device on an EM-CCD
camera with single photon sensitivity with simultaneous 488, 561, and 642 nm laser excitation (Tian et al., 2013).
(E) Pseudocolor image computed from the raw image using elastic channel registration (Arganda-Carreras et al., 2006) and optimal filtering (Sage et al., 2005).
(F) Oxygen is reduced by an enzymatic oxygen scavenger system.
(G) The photophysics of a fluorescence dye may be described by a Jablonski diagram with the ground and first excited singlet states, S0 and S1, and the lowest
triplet state, T1. The long-lived T1 state is quenched by molecular oxygen forming highly reactive singlet oxygen, but in presence of an oxygen scavenger, other
methods are necessary to deplete the T1 state, which otherwise is highly susceptible to photobleaching (Vogelsang et al., 2008).
(H) Trolox and methyl viologen form a reducing and oxidizing system that rapidly depletes the T1 state.
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dynamics simulations of the position distribution of the dye
and the linker dynamics can improve the accuracy of RET-based
distance measurements with dyes on longer linkers (Best et al.,
2007; Merchant et al., 2007; Muschielok et al., 2008; Schro¨der
et al., 2005; Sindbert et al., 2011).
Strategies to Attach Multiple Labels
The full potential of uaa mutagenesis will be harnessed when it
is combined with other protein modifications, such as protein
fusion tags for enzymatic labeling tags (SNAP, CLIP, etc.) or
autofluorescent proteins (e.g., GFP), classical Cys modification,
or native protein ligation (Beck-Sickinger and Budisa, 2012).
SNAP and CLIP are fast labeling tags with reactions rates 104–
105 M1 s1 (Hinner and Johnsson, 2010), but these tags are
182-residue polypeptides (19.4 kDa) and are typically limited
as fusion proteins to theN- or C-terminal parts of a target protein.
In case of GPCRs, attaching a tag to the N-terminal tail of the
receptor might result in loss of function. For example, the prote-
ase-activated receptor 1 (PAR1) is activated by a protease that
cleaves its N-terminal segment (Ludeman et al., 2005). Another
example is the adhesion GPCRs in which the N-terminal domain
undergoes autoproteolytic cleavage or is swapped with other
proteins (Arac¸ et al., 2012).
Other polytopic membrane proteins, such as the multidrug
resistance protein 1, have both N and C termini located on
the cytoplasmic side (Bibi and Be´ja`, 1994), and protein N- or
C-terminal fusion tags would not allow labeling of the extracel-Chemistry & Biology 2lular surface. On the other hand, bioorthogonal-labeling reac-
tions utilizing unique chemical handles on uaas enable labeling
on virtually any surface-exposed site on an expressed protein.
Besides the labeling strategies discussed above, other uaas
based on engineered pyrrolysine-tRNA synthetase, such as a
BCN derivative of pyrrolysine, enable Diels-Alder cycloaddition
reactions with tetrazines (Lang et al., 2012) and SpAAC reactions
with azido-containing labels (Borrmann et al., 2012).
In summary, the convergent technology platform described
above provides a new approach to study the dynamics of
GPCR signalosomes by SMD fluorescence methods. Tethered
membrane ‘‘chip’’ systems can be used to study the kinetics of
ligand-receptor interactions and receptor dynamics (Figure 7)
while other bioorthogonal labeling methods hold promise in
addressing the biology of GPCR oligomerization and functional
selectivity in live-cell systems.ACKNOWLEDGMENTS
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Figure 7. SMF Experiments with GPCR Signalosomes
The conceptual design of a supramolecular tethered assembly to study
GPCRs by multicolor SMD-TIRF imaging. Crystal structures of representative
proteins, albumin (Protein Data Bank [PDB]: 1GNJ), avidin (PDB: 1AVD),
IgG1 (PDB: 1IGY), CCR5 (PDB: 4MSB), human O6-alkylguanine-DNA alkyl-
transferase (AGT) (PDB: 1EH6), and AOP-RANTES (PDB: 1B3A), are manually
arranged to illustrate how biotinylated albumin is physically adsorbed to the
glass surface and is linked by (strept-) avidin to a biotinylated antibody. The
antigen-binding fragment (Fab) of the antibody captured the receptor (CCR5)
by an engineered C-terminal epitope. CCR5 is embedded in a nanoscale
apolipoprotein-bound bilayer (Banerjee et al., 2008; Knepp et al., 2011). TIRF
allows efficient excitation of fluorophores in the evanescent wave that extends
beyond the glass surface into the aqueous solution (Axelrod et al., 1984). The
receptor is labeled with an N-terminal engineered AGT tag (SNAP) (Keppler
et al., 2003) and/or with SpAAC modified, genetically encoded azF residues
(Alexa-DIBO-azF). Binding and release of fluorescent chemokines (RANTES-
A647) can be detected in FRET or two-color single-molecule colocalization
imaging experiments (Huber and Sakmar, 2011; Tian et al., 2013).
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